CV Sciences launches PlusHLTH.com direct-to-consumer site for PlusHLTH products

Reuters2026/08/12 02:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CV Sciences launched PlusHLTH.com to scale its direct-to-consumer platform beyond cannabinoids, widening its addressable health and nutrition market.
The move gives the +PlusHLTH line a dedicated digital channel, positioning PlusCBDOil.com to stay focused on hemp-derived CBD.
Management framed the site as a strategic base for new product rollouts, consumer education, and higher-margin brand building in healthy aging.
+PlusHLTH currently sells non-cannabinoid supplements and a plant-based protein product, with further line expansion planned across new formats.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CV Sciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608112230ACCESSWRNAPR_____1206335) on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23